|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Cano CE, Motoo Y and Iovanna JL:
Epithelial-to-mesenchymal transition in pancreatic adenocarcinoma.
ScientificWorldJournal. 10:1947–1957. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang H, Liu L, Wang Y, Zhao G, Xie R, Liu
C, Xiao X, Wu K, Nie Y, Zhang H and Fan D: KLF8 involves in
TGF-beta-induced EMT and promotes invasion and migration in gastric
cancer cells. J Cancer Res Clin Oncol. 139:1033–1042. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Le Bras GF, Taubenslag KJ and Andl CD: The
regulation of cell-cell adhesion during epithelial-mesenchymal
transition, motility and tumor progression. Cell Adh Migr.
6:365–373. 2012.PubMed/NCBI
|
|
5
|
Lim S, Becker A, Zimmer A, Lu J, Buettner
R and Kirfel J: SNAI1-mediated epithelial-mesenchymal transition
confers chemoresistance and cellular plasticity by regulating genes
involved in cell death and stem cell maintenance. PLoS One.
8:e665582013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu Q, Hou X, Xia J, Qian X, Miele L,
Sarkar FH and Wang Z: Emerging roles of PDGF-D in EMT progression
during tumorigenesis. Cancer Treat Rev. 39:640–646. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thomson S, Petti F, Sujka-Kwok I, Mercado
P, Bean J, Monaghan M, Seymour SL, Argast GM, Epstein DM and Haley
JD: A systems view of epithelial-mesenchymal transition signaling
states. Clin Exp Metastasis. 28:137–155. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu ZQ, Li XY, Hu CY, Ford M, Kleer CG and
Weiss SJ: Canonical Wnt signaling regulates Slug activity and links
epithelial-mesenchymal transition with epigenetic Breast Cancer 1,
Early Onset (BRCA1) repression. Proc Natl Acad Sci USA.
109:16654–16659. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Du R, Sun W, Xia L, Zhao A, Yu Y, Zhao L,
Wang H, Huang C and Sun S: Hypoxia-induced down-regulation of
microRNA-34a promotes EMT by targeting the Notch signaling pathway
in tubular epithelial cells. PLoS One. 7:e307712012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Z, Li Y, Kong D and Sarkar FH: The
role of Notch signaling pathway in epithelial-mesenchymal
transition (EMT) during development and tumor aggressiveness. Curr
Drug Targets. 11:745–751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim TH and Shivdasani RA: Notch signaling
in stomach epithelial stem cell homeostasis. J Exp Med.
208:677–688. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Penton AL, Leonard LD and Spinner NB:
Notch signaling in human development and disease. Semin Cell Dev
Biol. 23:450–457. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Palagani V, El Khatib M, Kossatz U, Bozko
P, Müller MR, Manns MP, Krech T, Malek NP and Plentz RR: Epithelial
mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+
cells are inhibited by γ-secretase inhibitor IX. PLoS One.
7:e465142012.
|
|
14
|
Miele L, Miao H and Nickoloff BJ: NOTCH
signaling as a novel cancer therapeutic target. Curr Cancer Drug
Targets. 6:313–323. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Z, Banerjee S, Li Y, Rahman KM, Zhang
Y and Sarkar FH: Down-regulation of Notch-1 inhibits invasion by
inactivation of nuclear factor-κB, vascular endothelial growth
factor, and matrix metalloproteinase-9 in pancreatic cancer cells.
Cancer Res. 66:2778–2784. 2006.
|
|
16
|
Wang Z, Zhang Y, Banerjee S, Li Y and
Sarkar FH: Inhibition of nuclear factor kappab activity by
genistein is mediated via Notch-1 signaling pathway in pancreatic
cancer cells. Int J Cancer. 118:1930–1936. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi TP, Xu H, Wei JF, Ai X, Ma X, Wang BJ,
Ju ZH, Zhang GX, Wang C, Wu ZQ and Zhang X: Association of low
expression of notch-1 and jagged-1 in human papillary bladder
cancer and shorter survival. J Urol. 180:361–366. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Reedijk M, Pinnaduwage D, Dickson BC,
Mulligan AM, Zhang H, Bull SB, O’Malley FP, Egan SE and Andrulis
IL: JAG1 expression is associated with a basal phenotype and
recurrence in lymph node-negative breast cancer. Breast Cancer Res
Treat. 111:439–448. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dickson BC, Mulligan AM, Zhang H, Lockwood
G, O’Malley FP, Egan SE and Reedijk M: High-level JAG1 mRNA and
protein predict poor outcome in breast cancer. Mod Pathol.
20:685–693. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu YM, Zhao WL, Fu JF, Shi JY, Pan Q, Hu
J, Gao XD, Chen B, Li JM, Xiong SM, et al: NOTCH1 mutations in
T-cell acute lymphoblastic leukemia: prognostic significance and
implication in multifactorial leukemogenesis. Clin Cancer Res.
12:3043–3049. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ma D, Dong X, Zang S, Ma R, Zhao P, Guo D,
Dai J, Chen F, Ye J and Ji C: Aberrant expression and clinical
correlation of Notch signaling molecules in breast cancer of
Chinese population. Asia Pac J Clin Oncol. 7:385–391. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou Q, Wang Y, Peng B, Liang L and Li J:
The roles of Notch1 expression in the migration of intrahepatic
cholangiocarcinoma. BMC Cancer. 13:2442013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ni X, Long J, Cen P, Chen L, Yang J and Li
M: Pancreatic cancer tumour initiating cells: the molecular
regulation and therapeutic values. J Cell Mol Med. 16:988–994.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Z, Ahmad A, Li Y, Azmi AS, Miele L
and Sarkar FH: Targeting notch to eradicate pancreatic cancer stem
cells for cancer therapy. Anticancer Res. 31:1105–1113.
2011.PubMed/NCBI
|
|
25
|
Brzozowa M, Mielańczyk L, Michalski M,
Malinowski L, Kowalczyk-Ziomek G, Helewski K, Harabin-Słowińska M
and Wojnicz R: Role of Notch signaling pathway in gastric cancer
pathogenesis. Contemp Oncol (Pozn). 17:1–5. 2013.PubMed/NCBI
|
|
26
|
Mori M, Miyamoto T, Yakushiji H, Ohno S,
Miyake Y, Sakaguchi T, Hattori M, Hongo A, Nakaizumi A, Ueda M and
Ohno E: Effects of N-[N-(3,
5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester
(DAPT) on cell proliferation and apoptosis in Ishikawa endometrial
cancer cells. Hum Cell. 25:9–15. 2012.
|
|
27
|
Subramaniam D, Ponnurangam S, Ramamoorthy
P, Standing D, Battafarano RJ, Anant S and Sharma P: Curcumin
induces cell death in esophageal cancer cells through modulating
Notch signaling. PLoS One. 7:e305902012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Becker KF, Rosivatz E, Blechschmidt K,
Kremmer E, Sarbia M and Höfler H: Analysis of the E-cadherin
repressor Snail in primary human cancers. Cells Tissues Organs.
185:204–212. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Saad S, Stanners SR, Yong R, Tang O and
Pollock CA: Notch mediated epithelial to mesenchymal transformation
is associated with increased expression of the Snail transcription
factor. Int J Biochem Cell Biol. 42:1115–1122. 2010. View Article : Google Scholar : PubMed/NCBI
|
